updat estim follow compani
pre-announce last week updat outlook effort
better reflect manag commentari morgan healthcar
confer also fine-tun forecast
rais adjust ep estim neg
reflect compani preliminari revenu expect
modestli stronger adjust ebitda perform quarter
given zbh commentari expect less organ growth
lower organ growth forecast year bp
also reduc currenc growth assumpt bp
neg result chang lower
adjust ep estim
lower adjust ep estim
reflect higher adjust tax rate forecast versu previous
versu bp gross margin expans previous
encourag wmgi strong revenu perform cartiva
give us increas confid compani abil meet exceed
financi target million revenu million adjust
ebitda cartiva acquisit regard seen sign
stabil hip knee implant market continu
hear compani product suppli issu larg resolv end
still think close organ growth could achiev
compani choos reflect littl conservat
forecast thesi remain although reduc
estim modestli continu believ compani becom
consist mid-single-digit grower organ twice fast bottom-lin
growth think still room multipl expans level
import pleas read disclosur disclaim page report
updat estim follow compani pre-announce last week
updat outlook effort better reflect manag commentari morgan
healthcar confer also fine-tun forecast
januari pre-announc preliminari revenu million
consensu expect million million forecast compani guidanc
million quarter wmgi cartiva acquisit primari driver revenu upsid
achiev million revenu versu compani guidanc million contrast total
compani organ growth includ four less sell day year-over-year day
basi larg consist expect product standpoint strong sale upper
extrem product organ biolog organ help off-set weak
lower extrem organ reflect greater headwind sale day chang
regard octob cartiva acquisit expect cartiva sale declin
sequenti million rang cartiva revenu drop
immedi announc agreement acquir compani late august point
cartiva distributor expect termin focus attent
product sale bag howev made offer retain roughli
cartiva dealer dealer agre contract includ narrow sale territori
renegoti account cartiva sale reacceler engag
contract talk mani cartiva distributor compani appear well posit meet exceed
cartiva sale target million move past distributor contract renegoti open
product mani lower extrem sale repres year
comfort enough perform reaffirm adjust ebitda guidanc
million said would surpris see adjust ebitda end modestli
assum adjust ebitda contribut cartiva acquisit would guess
revenu upsid drop oper profit
highlight sever key product launch morgan healthcar confer
present includ reviv revis shoulder system launch ortholoc sp shoulder
fractur plate system launch lower extrem cartiva synthet cartilag implant big
toe arthriti provid meaning new sale opportun wmgi sale forc compani
continu ramp-up launch prosteo mi instrument note
signific surgeon interest prostep manag indic domest adopt curv
product littl longer anticip tri address
modif train approach includ personnel avail provid assist
greater number earli case
addit preannounc preliminari revenu also provid financi target
time-frame includ double-digit constant currenc sale growth year adjust gross
margin hold high rang adjust ebitda margin exit rate
compani also continu expect reach adjust ebitda margin full quarter
rais adjust ep estim neg reflect compani
preliminari revenu expect modestli stronger adjust ebitda perform
provid updat feedback regard move piec outlook present
 session morgan healthcar confer last week specif compani indic
follow
anticip total compani organ growth expect
includ previous disclos million increment revenu headwind loss
bone cement distribut agreement heraeu medic palaco notabl compani
continu expect grow in-lin market rate view
januari expect chang foreign currenc exchang rate reduc
revenu growth bp compani expect time
view chang year-over-year sell day signific headwind revenu growth
signific tailwind revenu growth impact full year
continu expect full year tax rate level
view market growth closer model organ growth
compani given zbh commentari expect less organ growth
lower forecast bp also reduc currenc growth
assumpt bp neg result chang lower
adjust ep estim
regard sell day count one less day year-over-year one extra day year-
over-year updat forecast accordingli given zbh comment would guess
intern sale day chang adjust weigh heavili
fine-tun estim reflect conserv adjust tax rate adjust
gross margin assumpt regard adjust tax rate prior convers
manag suggest compani view adjust tax rate sustain continu
believ adjust tax rate remain good estim come benefit
favor discret item think reason assumpt
previous particularli earli year
regard itgr adjust gross margin expect stabl year-over-year perform
bp improv previous continu modest year-over-year contract
initi benefit manufactur initi compani launch juli
start aid result total believ itgr expect manufactur initi
drive improv manufactur improv
manufactur facil meaning improv manufactur facil
lower adjust ep estim reflect higher adjust tax
rate forecast slightli lower adjust gross margin assumpt notabl follow strong
continu expect grow organ revenu similar market rate rang
believ compani expect see meaning impact sale growth custom
initi strateg plan time-frame
 annual forma incom statement analysi adjust northcoast research thousand except percentag per share net gross gross sg amort intang sg amort oper oper net interest expens expens incom incom tax adjust net incom continu adjust net margin continu extra item continu net incom continu incom discontinu net wghd com share adjust ep continu ep continu ep growth ep growth yr/yr n/an/an/an/an/asourc compani report northcoast research estim adjust ep exclud amort expens start revenu reflect salto ankl larg joint divestitur respect
inc annual incom statement analysi adjust northcoast research million except percentag per share gross gross sg sg oper oper net interest incom net interest incom incom incom incom tax minor incom extra incom extra extra net net wghd com share ep ep growth ep growth exclud amort intang asset adjust ep start compani report northcoast research estim
integ hold corporationannu incom statement adjust northcoast research thousand except percent per share net gross gross sg rd sg rd oper oper interest interest expens incom incom tax incom extra incom extra extra net incom continu net margin continuin wghd com share ep ep revenu growth adjust ep growth compani report northcoast research estim exclud amort intang asset adjust ep start disclosur
